Literature DB >> 9180174

Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts.

N L Michael1, A E Brown, R F Voigt, S S Frankel, J R Mascola, K S Brothers, M Louder, D L Birx, S A Cassol.   

Abstract

A patient is described who rapidly progressed from primary human immunodeficiency virus (HIV) type 1 infection to death without seroconversion but with consistently high plasma viremia. His asymptomatic sex partner had been HIV-1 seropositive for >8 years prior to transmission. Analysis of viral sequences from these subjects and controls confirmed the transmission event. Although the biologic properties of the patient's virus were unremarkable, he had poor functional immune responses to HIV and an HLA haplotype associated with rapid disease progression. The disparity between immune responses and clinical course in this transmission pair, coupled with infection with an unremarkable HIV-1 isolate, underscores the crucial importance of host factors in HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180174     DOI: 10.1086/516467

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Authors:  S I Staprans; P J Dailey; A Rosenthal; C Horton; R M Grant; N Lerche; M B Feinberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Rapid HIV progression during acute HIV-1 subtype C infection in a Mozambican patient with atypical seroconversion.

Authors:  Cesar Velasco; Erica Parker; Lucia Pastor; Abel Nhama; Salesio Macuacua; Inácio Mandomando; Julià Blanco; Denise Naniche
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

4.  Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS.

Authors:  Charles R Brown; Meggan Czapiga; Juraj Kabat; Que Dang; Ilnour Ourmanov; Yoshiaki Nishimura; Malcolm A Martin; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection.

Authors:  J D Lifson; M A Nowak; S Goldstein; J L Rossio; A Kinter; G Vasquez; T A Wiltrout; C Brown; D Schneider; L Wahl; A L Lloyd; J Williams; W R Elkins; A S Fauci; V M Hirsch
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Variability in a dominant block to SIV early reverse transcription in rhesus monkey cells predicts in vivo viral replication and time to death.

Authors:  Thomas F Rogers; So-Yon Lim; T J Sundsvold; Tiffany Chan; Ariel Hsu; Norman L Letvin
Journal:  Virol J       Date:  2010-04-26       Impact factor: 4.099

7.  Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Authors:  Vanessa M Hirsch; Sampa Santra; Simoy Goldstein; Ronald Plishka; Alicia Buckler-White; Aruna Seth; Ilnour Ourmanov; Charles R Brown; Ronald Engle; David Montefiori; Jennifer Glowczwskie; Kevin Kunstman; Steven Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

Authors:  Judith Dalmau; Maria Carmen Puertas; Marta Azuara; Ana Mariño; Nicole Frahm; Beatriz Mothe; Nuria Izquierdo-Useros; Maria José Buzón; Roger Paredes; Lourdes Matas; Todd M Allen; Christian Brander; Carlos Rodrigo; Bonaventura Clotet; Javier Martinez-Picado
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

Review 9.  Mucosal immunology of HIV infection.

Authors:  Huanbin Xu; Xiaolei Wang; Ronald S Veazey
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Fatal HIV encephalitis in HIV-seronegative patients.

Authors:  Troy M Martin; Josiah D Rich
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.